US 11116838
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy
granted A61KA61K2039/505A61K2039/53
Quick answer
US patent 11116838 (Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy) held by Inovio Pharmaceuticals, Inc. expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61K2039/53, A61K2039/545, A61K2039/585